Bowel cancer charities have criticised a decision by the watchdog NICE to refuse NHS funding for a drug in England and Wales.
Health economist Zack Cooper explains why the watchdog would reject the drug Avastin.
Get in touch with Today via
email
,
Twitter
or
Facebook
or text us on 84844.
Bookmark with:
What are these?
E-mail this to a friend